etrasimod: Clinical Trials

5 terminated. 5 Phase 2, 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	5	Terminated 5
Phase 3	2	Terminated 2

Follow etrasimod: new trials by email Literature Review of etrasimod trials Research Report on etrasimod

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection etrasimod, Placebo - Atopic Dermatitis, Atopic Dermatitis, Unspecified	Phase 2 / Phase 3	Terminated	Pfizer	58	2023-01-18	2025-05-08
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease Etrasimod, Placebo - Crohn's Disease	Phase 2 / Phase 3	Terminated	Pfizer	379	2020-01-06	2026-07-01
Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis APD334 - Primary Biliary Cholangitis	Phase 2	Terminated	Arena Pharmaceuticals	2	2017-12-29	2022-03-24
Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations APD334 - Inflammatory Bowel Diseases, Skin Extra-intestinal Manifestations	Phase 2	Terminated	Arena Pharmaceuticals	1	2017-07-17	2020-12-31
Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum APD334 - Pyoderma Gangrenosum	Phase 2	Terminated	Arena Pharmaceuticals	2	2017-06-07	2021-06-11

Conditions studied

Inflammatory Bowel Diseases (2)  ·  Crohn Disease (1)  ·  Dermatitis, Atopic (1)  ·  Eczema (1)  ·  Liver Cirrhosis, Biliary (1)  ·  Pyoderma Gangrenosum (1)

Sponsors

Arena Pharmaceuticals (3)  ·  Pfizer (2)

Countries

Australia (3)  ·  United States (3)  ·  Belgium (2)  ·  Canada (2)  ·  Czechia (2)  ·  Germany (2)  ·  New Zealand (2)  ·  Poland (2)  ·  Serbia (2)  ·  Argentina (1)  ·  Austria (1)  ·  Belarus (1)  ·  Bulgaria (1)  ·  Chile (1)  ·  Colombia (1)

Top investigators

Arena CT.gov Administrator (2)

Results publications

PMID 39575597